“…The synthetic route for these diazirine‐based crosslinkers is depicted in Figure S1 (Supporting Information). In specific, an intermediate, 4‐[3‐(Trifluoromethyl)‐3H‐diazirin‐3‐yl]benzoic acid, was synthesized following the method described by Sakurai et al [ 33 , 34 ] and then coupled with ethylene glycol, 1,11‐undecanediol, and tetraethylene glycol to produce the crosslinkers CL‐C2, CL‐C11, and CL‐TEG, respectively. Thus, the three crosslinker variants, CL‐C2, CL‐C11, and CL‐TEG, share a common functional group, yet they exhibit variations in their bridge chain lengths.…”